The HIV-1 non-subtype B workgroup: An international collaboration for the collection and analysis of HIV-1 non-subtype B data

MedGenMed Medscape General Medicine

Volumn 7, Issue 1, 2005, Pages

  Kantor, Rami ^a   Shafer, Robert W ^b   Katzenstein, David ^b  

^a BROWN UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; POL PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL TRIAL; FOOD AND DRUG ADMINISTRATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MEDICAL LITERATURE; NONHUMAN; PHENOTYPE; SEQUENCE ANALYSIS; SEROPREVALENCE; TREATMENT FAILURE; VIRUS MUTATION;

EID: 25144524626     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: 10.1186/1758-2652-7-1-71     Document Type: Article

References (15)

1. Robertson DL, Anderson JP, Bradac JA, et al. HIV-1 Nomenclature Proposal: A Reference Guide to HIV-1 Classification. In: Kuiken CL, Foley B, Hahn BH, et al, eds. Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic and Amino Acid Sequences. Los Alamos, NM: Los Alamos National Laboratory; 2000:492-505. Available at: http://www.hiv.lanl.gov/content/hiv-db/COMPENDIUM/1999/6/ nomenclature.pdf Accessed February 3, 2005.
2. Clavel F, Hance AJ. HIV drug resistance. N Engl J Med. 2004;350:1023-1035.
3. Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr. 2002;29:184-190.
4. Ravela J, Betts BJ, Brun-Vezinet F, et al. HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms. J Acquir Immune Defic Syndr. 2003;33:8-14.
5. Weidle PJ, Malamba S, Mwebaze R, et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet. 2002;360:34-40.
6. Pillay D, Walker AS, Gibb DM, et al. Impact of Human Immunodeficiency Virus Type 1 Subtypes on Virologic Response and Emergence of Drug Resistance among Children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial. J Infect Dis. 2002;186:617-625.
7. Kantor R, Katzenstein D, Camacho R, et al. Genotypic analyses of RT and protease sequences from persons infected with non- subtype B HIV-1. Program and abstracts of the 10th Conference on Retroviruses and Opportunistic Infections; February 10-14, 2003; Boston, Massachusetts. Abstract 623.
8. Dumans AT, Soares MA, Machado ES, et al. Synonymous genetic polymorphisms within Brazilian human immunodeficiency virus Type 1 subtypes may influence mutational routes to drug resistance. J Infect Dis. 2004;189:1232-1238.
9. Kantor R, Carvalho AP, Wynhoven B, et al. Nucleic acid differences between HIV-1 non-B and B reverse transcriptase and protease sequences at drug resistance positions. Antivir Ther. 2003;8:S58.
10. D'Aquila RT, Schapiro JM, Brun-Vezinet F, et al. Drug resistance mutations in HIV-1. Top HIV Med. 2003;11:92-96.
11. Shafer RW, Jung DR, Betts BJ. Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries. Nat Med. 2000;6:1290-1292.
12. Van Laethem K, De Luca A, Antinori A, Cingolani A, Perna CF, Vandamme AM. A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients. Antivir Ther. 2002;7:123-129.
13. Meynard JL, Vray M, Morand-Joubert L, et al. Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial. AIDS. 2002;16:727-736.
14. Brenner B, Turner D, Oliveira M, et al. A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. AIDS. 2003;17, F1-F5.
15. Kantor R, Shafer RW, Efron B, et al. HIV-1 subtype-related differences in genotypic evolution: analysis of subtypes B and C reverse transcriptase and protease sequences. Program and abstracts of the 11th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2004; San Francisco, California. Abstract 59.